Skip to main content
. 2012 Jun 28;18(24):3058–3069. doi: 10.3748/wjg.v18.i24.3058

Table 3.

Prevention of pancreatic fistula

There is currently no favored pancreatico-digestive anastomotic technique with regard to decreased pancreatic fistula rates
The routine use of octreotide can only be recommended in the case of:
Friable pancreatic tissue
Small diameter of the main pancreatic duct (< 3 mm)
Trans-anastomotic, percutaneously placed drainage of the main pancreatic duct decreases the risk of pancreatic fistula formation